#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12762	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2074	605.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	765	C	744	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12762	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2074	605.1	0	HET	.	.	.	C207T	.	207	207	C	438	438	C	693	C,T	529,128	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23462	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3668	632.9	0	.	n	.	0	T695C	SNP	695	695	T	1087	1087	C	734	C	711	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23462	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3668	632.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	2030	2030	G	767	G,A	374,372	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23462	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3668	632.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2363	2363	C	695	C,A	670,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23462	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3668	632.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2437	2437	A	719	A	698	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23462	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3668	632.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2989	2989	C	714	C	694	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1506	folP	855	855	100.0	folP.l6.c30.ctg.1	1702	87.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1135	1137	AGC	155;153;155	A;G;C	152;150;151	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3405	131.0	1	SNP	p	S91F	1	.	.	271	273	TTC	564	566	TTC	148;148;149	T;T;C	144;144;143	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3405	131.0	1	SNP	p	D95G	1	.	.	283	285	GGC	576	578	GGC	140;137;138	G;G,C;C	135;132,1;135	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3405	131.0	1	SNP	p	G95N	0	.	.	283	285	GGC	576	578	GGC	140;137;138	G;G,C;C	135;132,1;135	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1412	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1428	97.7	1	SNP	p	G45D	0	.	.	133	135	GGC	558	560	GGC	159;155;153	G;G,C;C	152;151,1;148	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	766	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	886	85.4	0	.	n	.	0	A197.	DEL	197	197	A	541	541	A	180	A	176	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4090	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3003	134.6	1	SNP	p	D86N	0	.	.	256	258	GAC	552	554	GAC	144;144;147	G;A;C	140;137;143	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4090	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3003	134.6	1	SNP	p	R87I	0	.	.	259	261	CGT	555	557	CGT	147;146;145	C;G;T	141;140;140	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4090	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3003	134.6	1	SNP	p	R87W	0	.	.	259	261	CGT	555	557	CGT	147;146;145	C;G;T	141;140;140	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4090	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3003	134.6	1	SNP	p	S87R	1	.	.	259	261	CGT	555	557	CGT	147;146;145	C;G;T	141;140;140	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4090	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3003	134.6	1	SNP	p	S88P	0	.	.	262	264	TCC	558	560	TCC	146;145;143	T;C,A;C	139;138,1;136	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3250	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2472	129.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1464	1466	GGC	169;168;167	G;G;C	165;164;161	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2279	144.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1242	1244	GCC	192;193;192	G;C,T;C	185;183,1;184	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2279	144.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1245	1247	ATG	195;194;198	A;T;G	186;187;191	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2279	144.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1257	1259	ACC	200;199;201	A;C,A;C,T	190;193,1;194,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2279	144.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1257	1259	ACC	200;199;201	A;C,A;C,T	190;193,1;194,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2279	144.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1758	1760	ACC	147;149;150	A;C;C	141;145;145	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2279	144.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1812	1814	GCG	156;157;156	G;C;G	147;148;144	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2279	144.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1812	1814	GCG	156;157;156	G;C;G	147;148;144	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2279	144.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1935	1937	GGT	129;128;127	G;G;T	124;124;121	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2279	144.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1944	1946	AGC	127;126;123	A;G;C	120;121;117	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3340	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2279	144.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1962	1964	CCG	99;103;98	C,G;C,G;G	80,5;87,3;80	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4958	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3004	163.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1568	1570	CCG	168;168;166	C;C;G	161;164;152	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1848	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1762	103.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	580	580	C	126	C	120	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2548	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1763	142.6	0	.	p	.	0	I45V	NONSYN	133	135	ATT	584	586	GTT	177;175;174	G;T;T	174;171;170	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2548	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1763	142.6	0	.	p	.	0	G256D	NONSYN	766	768	GGT	1217	1219	GAT	191;190;191	G;A;T	182;184;182	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2548	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1763	142.6	1	SNP	p	G120K	1	.	.	358	360	AAG	809	811	AAG	196;197;196	A;A;G	183;191;180	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2548	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1763	142.6	1	SNP	p	N121D	0	.	.	361	363	AAC	812	814	AAC	200;202;204	A;A;C	190;195;196	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2548	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1763	142.6	1	SNP	p	A121N	1	.	.	361	363	AAC	812	814	AAC	200;202;204	A;A;C	190;195;196	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8608	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4831	176.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	936	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1001	92.1	1	SNP	p	V57M	1	.	.	169	171	ATG	514	516	ATG	177;178;175	A;T;G	171;172;170	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
